Phoenix Life Sciences International Announces Maturine Carlot-Tary as Director of Health and Nutrition

DENVER, CO, May 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life” or the “Company”), an adaptive healthcare solutions company, today announced that Ms. Maturine Carlot-Tary has joined the Company as Director of Health and Nutrition.

Ms. Maturine Carlot-Tary possesses a strong background in health science with a diploma in Dietetics and Public Health Nutrition from the Fiji School of Medicine and Bachelor of Arts double major in Economics and Human Biosciences from the University of New England. While serving as the Director of Health Planning and Administration for the Ministry of Health in Vanuatu, she gained valuable experience in supervising the following sections: Finance, Human Resources, Health Research & Ethics, WHO open Learning, Vanuatu Centre for Nursing Education, Health Planning, Health Projects, Donor Coordination, Health Information Systems, Central Medical Stores and Pharmacy. In her other role as Director General of Health for the Vanuatu Ministry of Health, Ms. Maturine Carlot-Tary met with diplomatic corporate partners to address global health issues in Vanuatu, the Pacific and the world. She has presented various Health Papers in the country and overseas. She also held the position of Chairperson of the Vanuatu Medical and Ethics Research Committee and utilized her dietetics training to provide clients with individualized diet counseling to promote improved overall health. She coordinated the Vanuatu 2nd National Nutrition Survey 1996 co-authors with University of Queensland Epidemiologists and the Vanuatu National Non-Communicable Disease Survey 1998 co-authors with SPC Noumea.

“Maturine has spent over twenty years working within the Republic of Vanuatu’s Ministry of Health and doing consultancy work for other government agencies such as Ministry of Internal Affairs, Vanuatu Police Force and Ministry of Justice and Community Affairs. I am confident that she will provide Phoenix Life with her professional ethics guidance and valuable insight into the needs of the Vanuatu people as we expand our operations throughout the country,” said Martin Tindall, Chief Executive Officer of Phoenix Life. “As we move forward into clinical trials, Phoenix Life intends to utilize Maturine’s strong understanding of medical research ethics and best practices for safety and efficacy to best aid the Ni-Vanuatu people.”

“I am humbled by the opportunity to join Phoenix Life in its mission to transform global healthcare, starting with my home country of Vanuatu,” said Maturine Carlot-Tary, Director of Health and Nutrition. “Addressing global health has been a passion of mine for many years and I am proud to join a company that shares that value.”

To learn more about Phoenix Life Sciences International, please visit To learn more about Phoenix Life’s work in Vanuatu and how to register for blood sugar screenings, please visit

About Phoenix Life Sciences International Limited

Phoenix Life Sciences International Limited is an adaptive healthcare solutions company. Our business is to advance research and integrate programs and manufacturing of products that target and treat diabetes, pain, cancer, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. We strive to create partnerships and integrate these programs for human health into communities worldwide as part of our Global Health Initiative.


Information contained in this press release regarding Phoenix Life Sciences International, Limited and its subsidiaries, (the “Companies”) may constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements. The words “plan”, “forecast”, “anticipates”, “estimate”, “project”, “intend”, “expect”, “should”, “believe,” and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to, known and unknown risks, uncertainties and other factors which could cause the Company’s actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company’s filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to the Companies herein are expressly qualified in their entirety by the above-mentioned cautionary statement. The Companies disclaim any obligation to update forward-looking statements contained in this press release, except as may be required by law.


These statements have not been evaluated by the FDA and therefore the products sold by Phoenix Life Sciences International are not available in the U.S.


Phoenix Life Sciences International does not sell or distribute any products in the United States that are in violation of the United States Controlled Substances Act (US.CSA). This company does not grow, sell, and distribute cannabis-based products in the United States and is solely involved with the legal distribution of medical cannabis-based products within certain international markets outside of the United States.


Contact Data